Pentoxifylline alleviates vascular impairment in insulin resistance via TNF-α inhibition

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 384, Issue 3, 2011, Pages 277-285

  El Bassossy, Hany M ^a,b   El Moselhy, Mohamed A ^c   Mahmoud, Mona F ^b  

^a WAKE FOREST BAPTIST HEALTH   (United States)

^b Zagazig University   (Egypt)

^c Minia University   (Egypt)

Author keywords

Aorta; Contraction; Insulin resistance; Pentoxifylline; Relaxation; Tumor necrosis factor

Indexed keywords

ACETYLCHOLINE; DRINKING WATER; FRUCTOSE; GLUCOSE; INSULIN; NITRIC OXIDE; PENTOXIFYLLINE; PHENYLEPHRINE; POTASSIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CELL INFILTRATION; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; IN VITRO STUDY; INHIBITION KINETICS; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; ISOLATED ARTERY; LEUKOCYTE; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; RAT; VASCULAR DISEASE;

ANIMALS; AORTA, THORACIC; BLOOD GLUCOSE; CHEMOTAXIS, LEUKOCYTE; CONNECTIVE TISSUE; ENDOTHELIAL CELLS; FRUCTOSE; INSULIN; INSULIN RESISTANCE; MALE; PENTOXIFYLLINE; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 80054945074     PISSN: 00281298     EISSN: 14321912     Source Type: Journal    
DOI: 10.1007/s00210-011-0669-z     Document Type: Article

References (37)

1. Ascenzi P, di Masi A, Sciorati C, Clementi E (2010) Peroxynitrite-An ugly biofactor? Biofactors 36:264-273
2. Balletshofer BM, Rittig K, Stock J et al (2003) Insulin resistant young subjects at risk of accelerated atherosclerosis exhibit a marked reduction in peripheral endothelial function early in life but not differences in intima-media thickness. Atherosclerosis 171:303-309 (Pubitemid 37486083)
3. Baraka AM, Guemei A, Gawad HA (2010) Role of modulation of vascular endothelial growth factor and tumor necrosis factor-alpha in gastric ulcer healing in diabetic rats. Biochem Pharmacol 79:1634-1639
4. Barham D, Trinder P (1972) An improved colour reagent for the determination of blood glucose by the oxidase system. Analyst 97:142-145
5. Busija DW, Miller AW, Katakam P, Erdos B (2006) Adverse effects of reactive oxygen species on vascular reactivity in insulin resistance. Antioxid Redox Signal 8:1131-1140 (Pubitemid 44182413)
6. Carmassi F, De Negri F, Fioriti R et al (2005) Insulin resistance causes impaired vasodilation and hypofibrinolysis in young women with polycystic ovary syndrome. Thromb Res 116:207-214 (Pubitemid 40776019)
7. Chen H (2006) Cellular inflammatory responses: novel insights for obesity and insulin resistance. Pharmacol Res 53:469-477 (Pubitemid 43767552)
8. De Vriese AS, Verbeuren TJ, Van de Voorde J, Lameire NH, Vanhoutte PM (2000) Endothelial dysfunction in diabetes. Br J Pharmacol 130:963-974 (Pubitemid 30453529)
9. DeFronzo RA, Del Prato S (2009) Insulin resistance and diabetes mellitus. J Diabetes Complicat 10:243-245
10. Doherty GM, Jensen JC, Alexander HR, Buresh CM, Norton JA (1991) Pentoxifylline suppression of tumor necrosis factor gene transcription. Surgery 110:192-198
11. El-Bassossy HM, El-Maraghy NN, El-Fayoumi HM, Watson ML (2009) Haem oxygenase-1 induction protects against tumour necrosis factor alpha impairment of endothelial-dependent relaxation in rat isolated pulmonary artery. Br J Pharmacol 158:1527-1535
12. El-Ghoneimi A, Cursio R, Schmid-Alliana A et al (2007) Pentoxifyl-line inhibits liver expression of tumor necrosis factor alpha mRNA following normothermic ischemia-reperfusion. HPB (Oxford) 9:112-11 9 (Pubitemid 46672384)
13. Erdos B, Miller AW, Busija DW (2002) Impaired endothelium-mediated relaxation in isolated cerebral arteries from insulin-resistant rats. Am J Physiol Heart Circ Physiol 282:H2060-H2065 (Pubitemid 34663014)
14. Frangogiannis NG, Smith CW, Entman ML (2002) The inflammatory response in myocardial infarction. Cardiovasc Res 53:31-47 (Pubitemid 34020764)
15. Fuller CJ, Agil A, Lender D, Jialal I (2007) Superoxide production and LDL oxidation by diabetic neutrophils. J Diabetes Complicat 10:206-210
16. Giardina JB, Green GM, Cockrell KL, Granger JP, Khalil RA (2002) TNF-alpha enhances contraction and inhibits endothelial NO-cGMP relaxation in systemic vessels of pregnant rats. Am J Physiol Regul Integr Comp Physiol 283:R130-R143 (Pubitemid 34863918)
17. Haddad JJ, Land SC, Tarnow-Mordi WO, Zembala M, Kowalczyk D, Lauterbach R (2002) Immunopharmacological potential of selective phosphodiesterase inhibition. I. differential regulation of lipopolysaccharide-mediated proinflammatory cytokine (interleukin-6 and tumor necrosis factor-alpha) biosynthesis in alveolar epithelial cells. J Pharmacol Exp Ther 300:559-566
18. Hui YH, Huang NH, Ebbert L et al (2007) Pharmacokinetic comparisons of tail-bleeding with cannula-or retro-orbital bleeding techniques in rats using six marketed drugs. J Pharmacol Toxicol Methods 56:256-264 (Pubitemid 47375130)
19. Iyer SN, Katovich MJ (1996) Vascular reactivity to phenylephrine and angiotensin II in hypertensive rats associated with insulin resistance. Clin Exp Hypertens 18:227-242 (Pubitemid 26109955)
20. Manfredi AA, Sabbadini MG, Ferri L, Bianchi ME, Rovere-Querini P (2004) Mechanisms of systemic vasculitis. Drug Discov Today: Dis Mech 1:297-302 (Pubitemid 41128953)
21. Marcinkiewicz J, Grabowska A, Lauterbach R, Bobek M (2000) Differential effects of pentoxifylline, a non-specific phosphodi-esterase inhibitor, on the production of IL-10, IL-12 p40 and p35 subunits by murine peritoneal macrophages. Immunopharmacol 49:335-343
22. Marks JB, Raskin P (2003) Cardiovascular risk in diabetes: a brief review. J Diabetes Complicat 14:108-115
23. McKendrick JD, Salas E, Dube GP, Murat J, Russell JC, Radomski MW (1998) Inhibition of nitric oxide generation unmasks vascular dysfunction in insulin-resistant, obese JCR:LA-cp rats. Br J Pharmacol 124:361-369 (Pubitemid 28248027)
24. Mukhopadhyay S, Hoidal JR, Mukherjee TK (2006) Role of TNFalpha in pulmonary pathophysiology. Respir Res 7:125
25. de Oliveira IS Jr, Maganhin CC, Ferraz Carbonel AA et al (2008) Effects of pentoxifylline on TNF-alpha and lung histopathol-ogy in HCL-induced lung injury. Clinics (Sao Paulo) 63:77-84
26. Pickup JC (2004) Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 27:813-823 (Pubitemid 38280558)
27. Raskin P (2010) Risk factors for the development of diabetic complications. J Diabetes Complicat 8:195-200
28. Sandoval J, Escobar J, Pereda J et al (2009) Pentoxifylline prevents loss of PP2A phosphatase activity and recruitment of histone acetyltransferases to proinflammatory genes in acute pancreatitis. J Pharmacol Exp Ther 331:609-617
29. Shaw SM, Shah MKH, Williams SG, Fildes JE (2009) Immunological mechanisms of pentoxifylline in chronic heart failure. Eur J Heart Fail 11:113-11 8
30. Shinozaki K, Ayajiki K, Nishio Y, Sugaya T, Kashiwagi A, Okamura T (2004) Evidence for a causal role of the renin-angiotensin system in vascular dysfunction associated with insulin resistance. Hypertension 43:255-262 (Pubitemid 38174184)
31. Smith AR, Visioli F, Frei B, Hagen TM (2006) Age-related changes in endothelial nitric oxide synthase phosphorylation and nitric oxide dependent vasodilation: evidence for a novel mechanism involving sphingomyelinase and ceramide-activated phosphatase 2A. Aging Cell 5:391-400 (Pubitemid 44322535)
32. Sprague AH, Khalil RA (2009) Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem Pharmacol 78:539-552
33. Takagawa Y, Berger ME, Hori MT, Tuck ML, Golub MS (2001) Long-term fructose feeding impairs vascular relaxation in rat mesen-teric arteries. Am J Hypertens 14:811-817 (Pubitemid 32682250)
34. Verma S, Bhanot S, Yao L, McNeill JH (1996) Defective endothelium-dependent relaxation in fructose-hypertensive rats. Am J Hypertens 9:370-376 (Pubitemid 26129025)
35. Visioli F (1999) Editorial: tumour necrosis factor as a potential target for the treatment of congestive heart failure. Pharmacol Res 40:91 (Pubitemid 29378086)
36. Viswanad B, Srinivasan K, Kaul CL, Ramarao P (2006) Effect of tempol on altered angiotensin II and acetylcholine-mediated vascular responses in thoracic aorta isolated from rats with insulin resistance. Pharmacol Res 53:209-215 (Pubitemid 43247533)
37. Wimalasundera R, Fexby S, Regan L, Hughes AD (2003) Effect of tumour necrosis factor-alpha and interleukin 1 beta on endothelium-dependent relaxation in rat mesenteric resistance arteries in vitro. Br J Pharmacol 138:1285-1294 (Pubitemid 36543126)